摘要
摘要目的探讨数字平板DSA下肝动脉二氧化碳造影在肝癌介入诊疗中的效果和安全性.方法对１６０例肝癌患者行肝动脉CO２－DSA造影检查(观察组),同期对１３５例行碘－DSA检查(对照组),对两者的图像质量和安全性进行对比.结果观察组的图像质量、门静脉显示评分和血管轮廓评分均明显优于对照组(P＜０．０５),其动静脉瘘检出率与对照组比较有显著差异(３１．８８％VS１８．５２％,P＜０．０５);两组不良反应评分比较,观察组明显低于对照组,差异有显著性(P＜０．０５).结论CO２作为无毒副作用、粘滞度低的良好造影剂,在数字平板DSA下行肝动脉造影,具有显示图像质量清晰、不良反应少等优点,值得在肝癌的临床诊疗中推广应用.关键词数字平板DSA;肝动脉造影;CO２;肝癌ThestudyofclinicalsignificanceandsafetyofCO２appliedtohepaticarteryangiographyintheinterventionaldiagnosisandtreatmentofhepaticcarcinomabyusingdigitalplateDSAAbstractObjectiveToinvestigatetheeffectandsafetyofCO２appliedtohepaticarteryangiographyintheinterventionaldiagnosisandtreatmentofhepatＧiccarcinomabyusingdigitalplateDSA．MethodsCO２－DSAwasperformedin１６０patientswithlivercancer(observationgroup),and１３５patientsunderwentioＧdine－DSA(controlgroup)．Theimagequalityandsafetyofthetwogroupswerecompared．ResultsObservationgroupofimagequality,portalshowsandvascuＧlarcontourscoreweresignificantlybetterthanthatofcontrolgroup(P＜０．０５),andthearteriovenousfistuladetectionratetherewassignificantdifferencecomＧparedwithcontrolgroup(３１．８８％VS１８．５２％,P＜０．０５);comparisonoftwogroupsofadversereactions,thescoreofobservationgroup,issignificantlylowerthanthecontrolgroupwithsignificantdifference(P＜０．０５)．Which２casesofacuterenalinjurycausedbyiohexolinthecontrolgroup．ConclusionAsagoodconＧtrastagentwithlowviscosityandlowviscosity,CO２usedinthehepaticarteryangiographyunderdigitaltabletDSA,showsaclearimagequality,lessadversereＧactionsK,eyanwdoirsdsworthyofpopularizationandapplicationintheclinicaldiagnosisandtreatmentoflivercancer．DigitaltabletDSA;Hepaticarteryangiography;CO２;Canceroftheliver中图分类号R４４５文献标识码B文章编号１００１－５３０２(２０１５)０９－０７１１－０２
出版日期
2015年09月19日（中国期刊网平台首次上网日期，不代表论文的发表时间）
